Compare Cigna Corp (CI) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Starbucks Corp — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Starbucks Corp trades at $106.53 (market cap $119.30B). The key difference: Starbucks Corp is the larger of the two by market cap, and Starbucks Corp pays the higher dividend (2.37%). Which is the better fit depends on your goals.
| CI | SBUX | |
|---|---|---|
Market Cap | $73.56B | $119.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $108.37 |
52-Week Low | $244.41 | $78.46 |
Enterprise Value | $98.27B | $138.12B |
Dividend Yield | 2.24% | 2.37% |
Volume | — | 7,493,833 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Starbucks (SBUX) trades at $105.58, up 0.4% today, with a bullish technical signal and recent earnings beats driving momentum. The stock shows strong fundamental recovery with Q2 2026 EPS of $0.85 beating estimates by 29%, while revenue growth and margin expansion support a raised 2026 outlook. Analyst consensus is split evenly between Buy and Hold, with a $113.60 price target suggesting modest upside from current levels.
The outlook is positive as operational improvements and traffic recovery underpin earnings growth, but high valuation multiples (P/E 61) and competitive pressures pose risks. Investor sentiment is cautiously optimistic, focusing on sustained execution of the turnaround strategy amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
